Drug Shortage Report for MINT-CITALOPRAM

Last updated on 2020-12-07 History
Report ID 121279
Drug Identification Number 02429713
Brand name MINT-CITALOPRAM
Common or Proper name Citalopram
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) CITALOPRAM
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30 count Blisters
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-07-28
Actual start date
Estimated end date 2021-02-28
Actual end date
Shortage status Actual shortage
Updated date 2020-12-07
Company comments
Health Canada comments
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-12-07 French Compare
v6 2020-12-07 English Compare
v5 2020-12-07 French Compare
v4 2020-12-07 English Compare
v3 2020-07-29 English Compare
v2 2020-07-28 French Compare
v1 2020-07-28 English Compare